Structure

Physi-Chem Properties

Molecular Weight:  824.4
Volume:  827.415
LogP:  3.782
LogD:  2.776
LogS:  -4.519
# Rotatable Bonds:  11
TPSA:  171.17
# H-Bond Aceptor:  14
# H-Bond Donor:  3
# Rings:  9
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.131
Synthetic Accessibility Score:  7.261
Fsp3:  0.565
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.706
MDCK Permeability:  2.4976112399599515e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.961
20% Bioavailability (F20%):  0.995
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.148
Plasma Protein Binding (PPB):  57.46881103515625%
Volume Distribution (VD):  1.495
Pgp-substrate:  36.28730010986328%

ADMET: Metabolism

CYP1A2-inhibitor:  0.003
CYP1A2-substrate:  0.989
CYP2C19-inhibitor:  0.037
CYP2C19-substrate:  0.874
CYP2C9-inhibitor:  0.073
CYP2C9-substrate:  0.14
CYP2D6-inhibitor:  0.83
CYP2D6-substrate:  0.356
CYP3A4-inhibitor:  0.837
CYP3A4-substrate:  0.937

ADMET: Excretion

Clearance (CL):  1.754
Half-life (T1/2):  0.019

ADMET: Toxicity

hERG Blockers:  0.925
Human Hepatotoxicity (H-HT):  0.823
Drug-inuced Liver Injury (DILI):  0.038
AMES Toxicity:  0.048
Rat Oral Acute Toxicity:  0.894
Maximum Recommended Daily Dose:  0.987
Skin Sensitization:  0.013
Carcinogencity:  0.072
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.935

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC489610

Natural Product ID:  NPC489610
Common Name*:   AQTQHPDCURKLKT-JKDPCDLQSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  AQTQHPDCURKLKT-JKDPCDLQSA-N
Standard InCHI:  InChI=1S/C46H56N4O10.H2O4S/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6;1-5(2,3)4/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3;(H2,1,2,3,4)/t28-,37+,38-,39-,42+,43-,44-,45+,46+;/m1./s1
SMILES:  CC[C@@]1(C[C@@H]2C[C@](c3cc4c(cc3OC)N(C=O)[C@@H]3[C@@]54CCN4CC=C[C@](CC)([C@@H]54)[C@H]([C@@]3(C(=O)OC)O)OC(=O)C)(c3c(CCN(C2)C1)c1ccccc1[nH]3)C(=O)OC)O.OS(=O)(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   249332
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002756] Vinca alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40305 Pseudoceratina verrucosa Species Pseudoceratinidae Eukaryota n.a. n.a. n.a. PMID[23489291]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2589 Cell Line Panel leukemia (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[12036377]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 251.19 nM PMID[12036377]
NPT2589 Cell Line Panel leukemia (Carcinoma cell lines) Homo sapiens TGI = -4.8 n.a. PMID[12036377]
NPT3877 Cell Line NSCLC Homo sapiens TGI = -4.8 n.a. PMID[12036377]
NPT2589 Cell Line Panel leukemia (Carcinoma cell lines) Homo sapiens LC50 = -3.2 n.a. PMID[12036377]
NPT3877 Cell Line NSCLC Homo sapiens LC50 = -3.6 n.a. PMID[12036377]
NPT4720 Cell Line Leukemia cells Homo sapiens GI50 = 7.0 n.a. PMID[16107161]
NPT517 Cell Line Panel NCI-60 (60 carcinoma cell lines) Homo sapiens GI50 = 6.7 n.a. PMID[16107161]
NPT4720 Cell Line Leukemia cells Homo sapiens TGI = 4.8 n.a. PMID[16107161]
NPT3877 Cell Line NSCLC Homo sapiens TGI = 4.8 n.a. PMID[16107161]
NPT6511 Cell Line Colon cells Homo sapiens TGI = 5.4 n.a. PMID[16107161]
NPT5530 Cell Line CNS cells Homo sapiens TGI = 5.2 n.a. PMID[16107161]
NPT3880 Cell Line Melanoma cells Homo sapiens TGI = 5.1 n.a. PMID[16107161]
NPT6428 Cell Line Ovarian carcinoma cells Homo sapiens TGI = 4.7 n.a. PMID[16107161]
NPT6593 Cell Line Renal cells Homo sapiens TGI = 4.7 n.a. PMID[16107161]
NPT6369 Cell Line Prostate cells Homo sapiens TGI = 5.2 n.a. PMID[16107161]
NPT5230 Cell Line Breast carcinoma cells Homo sapiens TGI = 5.1 n.a. PMID[16107161]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 6.6 n.a. PMID[16107161]
NPT517 Cell Line Panel NCI-60 (60 carcinoma cell lines) Homo sapiens TGI = 5.0 n.a. PMID[16107161]
NPT4720 Cell Line Leukemia cells Homo sapiens LC50 = 3.2 n.a. PMID[16107161]
NPT3877 Cell Line NSCLC Homo sapiens LC50 = 3.6 n.a. PMID[16107161]
NPT6511 Cell Line Colon cells Homo sapiens LC50 = 4.1 n.a. PMID[16107161]
NPT5530 Cell Line CNS cells Homo sapiens LC50 = 3.7 n.a. PMID[16107161]
NPT3880 Cell Line Melanoma cells Homo sapiens LC50 = 3.6 n.a. PMID[16107161]
NPT6428 Cell Line Ovarian carcinoma cells Homo sapiens LC50 = 3.5 n.a. PMID[16107161]
NPT6593 Cell Line Renal cells Homo sapiens LC50 = 3.6 n.a. PMID[16107161]
NPT6369 Cell Line Prostate cells Homo sapiens LC50 = 3.5 n.a. PMID[16107161]
NPT5230 Cell Line Breast carcinoma cells Homo sapiens LC50 = 3.5 n.a. PMID[16107161]
NPT6511 Cell Line Colon cells Homo sapiens GI50 = 7.0 n.a. PMID[16107161]
NPT517 Cell Line Panel NCI-60 (60 carcinoma cell lines) Homo sapiens LC50 = 3.6 n.a. PMID[16107161]
NPT5530 Cell Line CNS cells Homo sapiens GI50 = 6.9 n.a. PMID[16107161]
NPT3880 Cell Line Melanoma cells Homo sapiens GI50 = 6.8 n.a. PMID[16107161]
NPT6428 Cell Line Ovarian carcinoma cells Homo sapiens GI50 = 6.5 n.a. PMID[16107161]
NPT6593 Cell Line Renal cells Homo sapiens GI50 = 6.5 n.a. PMID[16107161]
NPT6369 Cell Line Prostate cells Homo sapiens GI50 = 6.9 n.a. PMID[16107161]
NPT5230 Cell Line Breast carcinoma cells Homo sapiens GI50 = 6.5 n.a. PMID[16107161]
NPT377 Cell Line OVCAR-3 Homo sapiens IC50 = 10.0 nM PMID[15857148]
NPT458 Cell Line IGROV-1 Homo sapiens IC50 = 10.0 nM PMID[15857148]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 10.0 nM PMID[15857148]
NPT2318 Cell Line A172 Homo sapiens IC50 > 100000.0 nM PMID[15857148]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 100.0 nM PMID[15857148]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 100.0 nM PMID[15857148]
NPT2589 Cell Line Panel leukemia (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[17154522]
NPT2589 Cell Line Panel leukemia (Carcinoma cell lines) Homo sapiens TGI = 15848.93 nM PMID[17154522]
NPT2589 Cell Line Panel leukemia (Carcinoma cell lines) Homo sapiens LC50 = 1584893192461.11 nM PMID[17154522]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 251.19 nM PMID[17154522]
NPT3877 Cell Line NSCLC Homo sapiens TGI = 15848.93 nM PMID[17154522]
NPT3877 Cell Line NSCLC Homo sapiens LC50 = 251188.64 nM PMID[17154522]
NPT116 Cell Line HL-60 Homo sapiens IC50 = 11.2 ug.mL-1 PMID[17432904]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 251.19 nM PMID[17559205]
NPT3877 Cell Line NSCLC Homo sapiens TGI = 15848.93 nM PMID[17559205]
NPT3877 Cell Line NSCLC Homo sapiens LC50 = 251188.64 nM PMID[17559205]
NPT4720 Cell Line Leukemia cells Homo sapiens GI50 = 100.0 nM PMID[19006285]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 251.19 nM PMID[19006285]
NPT3880 Cell Line Melanoma cells Homo sapiens GI50 = 158.49 nM PMID[19006285]
NPT4720 Cell Line Leukemia cells Homo sapiens TGI = 15848.93 nM PMID[19006285]
NPT3877 Cell Line NSCLC Homo sapiens TGI = 15848.93 nM PMID[19006285]
NPT3880 Cell Line Melanoma cells Homo sapiens TGI = 7943.28 nM PMID[19006285]
NPT4720 Cell Line Leukemia cells Homo sapiens LC50 = 630957.34 nM PMID[19006285]
NPT3877 Cell Line NSCLC Homo sapiens LC50 = 251188.64 nM PMID[19006285]
NPT3880 Cell Line Melanoma cells Homo sapiens LC50 = 251188.64 nM PMID[19006285]
NPT4720 Cell Line Leukemia cells Homo sapiens GI = 0.1 uM PMID[19006285]
NPT3877 Cell Line NSCLC Homo sapiens GI = 0.25 uM PMID[19006285]
NPT3880 Cell Line Melanoma cells Homo sapiens GI = 0.16 uM PMID[19006285]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 200.0 nM PMID[20395150]
NPT3877 Cell Line NSCLC Homo sapiens TGI = 15800.0 nM PMID[20395150]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 250.0 nM PMID[20684599]
NPT3877 Cell Line NSCLC Homo sapiens TGI = 15850.0 nM PMID[20684599]
NPT3877 Cell Line NSCLC Homo sapiens LC50 = 251190.0 nM PMID[20684599]
NPT858 Cell Line LNCaP Homo sapiens IC50 = 2.9 nM PMID[20732809]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 11.0 nM PMID[20732809]
NPT3877 Cell Line NSCLC Homo sapiens GI50 = 250.0 nM PMID[22283430]
NPT3877 Cell Line NSCLC Homo sapiens TGI = 15850.0 nM PMID[22283430]
NPT66 Individual Protein Acetylcholinesterase Electrophorus electricus Inhibition = 10.9 % PMID[23062825]
NPT1523 Cell Line NFF Homo sapiens IC50 = 17.0 nM PMID[23215348]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 15.0 nM PMID[23215348]
NPT858 Cell Line LNCaP Homo sapiens IC50 = 6.1 nM PMID[23215348]
NPT165 Cell Line HeLa Homo sapiens IC50 = 36.0 nM PMID[23215348]
NPT81 Cell Line A549 Homo sapiens IC50 = 20.0 nM PMID[23215348]
NPT1523 Cell Line NFF Homo sapiens IC50 = 16.9 nM PMID[23489291]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 15.3 nM PMID[23489291]
NPT165 Cell Line HeLa Homo sapiens IC50 = 35.8 nM PMID[23489291]
NPT2831 Cell Line P388/S Mus musculus Activity = 96.0 % PMID[430477]
NPT2831 Cell Line P388/S Mus musculus Activity = 138.0 % PMID[430477]
NPT2831 Cell Line P388/S Mus musculus Activity = 83.0 % PMID[430477]
NPT5929 Cell Line P388/VCR Mus musculus Activity = 0.0 % PMID[430477]
NPT5929 Cell Line P388/VCR Mus musculus Activity = 1.2 % PMID[430477]
NPT5929 Cell Line P388/VCR Mus musculus Activity = 0.9 % PMID[430477]
NPT5929 Cell Line P388/VCR Mus musculus Activity = 0.6 % PMID[430477]
NPT1161 Cell Line CHO Cricetulus griseus Activity = 40.0 % PMID[430477]
NPT1161 Cell Line CHO Cricetulus griseus Activity = 10.0 % PMID[430477]
NPT1034 Cell Line Lu1 Homo sapiens IC50 = 480.0 nM PMID[26522953]
NPT91 Cell Line KB Homo sapiens IC50 = 20.0 nM PMID[26522953]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 690.0 nM PMID[26522953]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 510.0 nM PMID[26522953]
NPT81 Cell Line A549 Homo sapiens IC50 = 171.5 nM PMID[28038323]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 116.6 nM PMID[28038323]
NPT457 Cell Line BT-549 Homo sapiens IC50 = 54.72 nM PMID[28038323]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 27.6 nM PMID[28038323]
NPT90 Cell Line DU-145 Homo sapiens IC50 = 72.3 nM PMID[28038323]
NPT612 Individual Protein Canalicular multispecific organic anion transporter 1 Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT1249 Individual Protein Canalicular multispecific organic anion transporter 2 Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT1028 Individual Protein Multidrug resistance-associated protein 4 Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT90 Cell Line DU-145 Homo sapiens IC50 = 71830.0 nM PMID[29174816]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 28110.0 nM PMID[29174816]
NPT25899 CELL-LINE Panel colon (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[12036377]
NPT25900 CELL-LINE Panel CNS (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[12036377]
NPT25901 CELL-LINE Panel melanoma (Carcinoma cell lines) Homo sapiens GI50 = 158.49 nM PMID[12036377]
NPT25902 CELL-LINE Panel ovarian (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[12036377]
NPT25903 CELL-LINE Panel renal (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[12036377]
NPT25904 CELL-LINE Panel prostate (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[12036377]
NPT25905 CELL-LINE Panel breast (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[12036377]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 199.53 nM PMID[12036377]
NPT25899 CELL-LINE Panel colon (Carcinoma cell lines) Homo sapiens TGI = -5.4 n.a. PMID[12036377]
NPT25900 CELL-LINE Panel CNS (Carcinoma cell lines) Homo sapiens TGI = -5.2 n.a. PMID[12036377]
NPT25901 CELL-LINE Panel melanoma (Carcinoma cell lines) Homo sapiens TGI = -5.1 n.a. PMID[12036377]
NPT25902 CELL-LINE Panel ovarian (Carcinoma cell lines) Homo sapiens TGI = -4.7 n.a. PMID[12036377]
NPT25903 CELL-LINE Panel renal (Carcinoma cell lines) Homo sapiens TGI = -4.7 n.a. PMID[12036377]
NPT25904 CELL-LINE Panel prostate (Carcinoma cell lines) Homo sapiens TGI = -5.2 n.a. PMID[12036377]
NPT25905 CELL-LINE Panel breast (Carcinoma cell lines) Homo sapiens TGI = -5.1 n.a. PMID[12036377]
NPT2 Others Unspecified TGI = -5.0 n.a. PMID[12036377]
NPT25899 CELL-LINE Panel colon (Carcinoma cell lines) Homo sapiens LC50 = -4.1 n.a. PMID[12036377]
NPT25900 CELL-LINE Panel CNS (Carcinoma cell lines) Homo sapiens LC50 = -3.7 n.a. PMID[12036377]
NPT25901 CELL-LINE Panel melanoma (Carcinoma cell lines) Homo sapiens LC50 = -3.6 n.a. PMID[12036377]
NPT25902 CELL-LINE Panel ovarian (Carcinoma cell lines) Homo sapiens LC50 = -3.5 n.a. PMID[12036377]
NPT25903 CELL-LINE Panel renal (Carcinoma cell lines) Homo sapiens LC50 = -3.6 n.a. PMID[12036377]
NPT25904 CELL-LINE Panel prostate (Carcinoma cell lines) Homo sapiens LC50 = -3.5 n.a. PMID[12036377]
NPT25905 CELL-LINE Panel breast (Carcinoma cell lines) Homo sapiens LC50 = -3.5 n.a. PMID[12036377]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = -3.6 n.a. PMID[12036377]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 < 0.1 nM PMID[15857148]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 1.0 nM PMID[15857148]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 100.0 nM PMID[15857148]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 10.0 nM PMID[15857148]
NPT25899 CELL-LINE Panel colon (Carcinoma cell lines) Homo sapiens GI50 = 100.0 nM PMID[17154522]
NPT25899 CELL-LINE Panel colon (Carcinoma cell lines) Homo sapiens TGI = 3981.07 nM PMID[17154522]
NPT25899 CELL-LINE Panel colon (Carcinoma cell lines) Homo sapiens LC50 = 79432.82 nM PMID[17154522]
NPT25900 CELL-LINE Panel CNS (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[17154522]
NPT25900 CELL-LINE Panel CNS (Carcinoma cell lines) Homo sapiens TGI = 6309.57 nM PMID[17154522]
NPT25900 CELL-LINE Panel CNS (Carcinoma cell lines) Homo sapiens LC50 = 199526.23 nM PMID[17154522]
NPT25901 CELL-LINE Panel melanoma (Carcinoma cell lines) Homo sapiens GI50 = 158.49 nM PMID[17154522]
NPT25901 CELL-LINE Panel melanoma (Carcinoma cell lines) Homo sapiens TGI = 7943.28 nM PMID[17154522]
NPT25901 CELL-LINE Panel melanoma (Carcinoma cell lines) Homo sapiens LC50 = 251188.64 nM PMID[17154522]
NPT25902 CELL-LINE Panel ovarian (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[17154522]
NPT25902 CELL-LINE Panel ovarian (Carcinoma cell lines) Homo sapiens TGI = 19952.62 nM PMID[17154522]
NPT25902 CELL-LINE Panel ovarian (Carcinoma cell lines) Homo sapiens LC50 = 251188.64 nM PMID[17154522]
NPT25903 CELL-LINE Panel renal (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[17154522]
NPT25903 CELL-LINE Panel renal (Carcinoma cell lines) Homo sapiens TGI = 19952.62 nM PMID[17154522]
NPT25903 CELL-LINE Panel renal (Carcinoma cell lines) Homo sapiens LC50 = 251188.64 nM PMID[17154522]
NPT25904 CELL-LINE Panel prostate (Carcinoma cell lines) Homo sapiens GI50 = 125.89 nM PMID[17154522]
NPT25904 CELL-LINE Panel prostate (Carcinoma cell lines) Homo sapiens TGI = 6309.57 nM PMID[17154522]
NPT25905 CELL-LINE Panel breast (Carcinoma cell lines) Homo sapiens GI50 = 316.23 nM PMID[17154522]
NPT25905 CELL-LINE Panel breast (Carcinoma cell lines) Homo sapiens TGI = 7943.28 nM PMID[17154522]
NPT25905 CELL-LINE Panel breast (Carcinoma cell lines) Homo sapiens LC50 = 316227.77 nM PMID[17154522]
NPT25904 CELL-LINE Panel prostate (Carcinoma cell lines) Homo sapiens LC50 = 316227.77 nM PMID[17154522]
NPT27 Others Unspecified IC50 = 26.7 ug.mL-1 PMID[17432904]
NPT27 Others Unspecified IC50 = 28.4 ug.mL-1 PMID[17432904]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 15848.93 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 1584893192461.11 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 3981.07 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 79432.82 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 125.89 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 6309.57 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 199526.23 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 158.49 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 7943.28 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 251188.64 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 316.23 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 19952.62 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 316227.77 nM PMID[17559205]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 125.89 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 316.23 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 3981.07 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 6309.57 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 19952.62 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 7943.28 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 79432.82 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 199526.23 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 316227.77 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 251188.64 nM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 0.1 uM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 0.13 uM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 0.32 uM PMID[19006285]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 15848.93 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 630957.34 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 251.19 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 251188.64 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 3981.07 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 79432.82 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 125.89 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 6309.57 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 199526.23 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 158.49 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 7943.28 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 316.23 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 19952.62 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 316227.77 nM PMID[18598018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 200.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 300.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 15800.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 4000.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 6300.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 7900.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 19900.0 nM PMID[20395150]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 15850.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 630960.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 3980.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 79430.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 130.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 6310.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 199530.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 160.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 7940.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 251190.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 320.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 19950.0 nM PMID[20684599]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 316230.0 nM PMID[20684599]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 100.0 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1000.0 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 199.53 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 3162.28 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 1584.89 nM PMID[19734910]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 50.12 nM PMID[19734910]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 320.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 130.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 160.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 15850.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 3980.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 6310.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 7940.0 nM PMID[22283430]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 19950.0 nM PMID[22283430]
NPT67 Individual Protein Cholinesterase Equus caballus Inhibition = 2.81 % PMID[23062825]
NPT27 Others Unspecified IC50 = 31.0 nM PMID[23215348]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 51.0 % PMID[430477]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 0.0 % PMID[430477]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 76.0 % PMID[430477]
NPT32 Organism Mus musculus Mus musculus LD50 = 2.1 mg.kg-1 PMID[430477]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 1.5 day PMID[430477]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 15.0 % PMID[430477]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 100.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 15850.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 630960.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 250.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 251190.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 3980.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 79430.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 160.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 7940.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 320.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 19950.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 316230.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 130.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 6310.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. LC50 = 199530.0 nM PMID[24747749]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 75.0 % PMID[412968]
NPT32 Organism Mus musculus Mus musculus LD50 = 2.1 mg.kg-1 PMID[412968]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. TGI = 77.0 % PMID[412968]
NPT29 Organism Rattus norvegicus Rattus norvegicus LD50 = 1.0 mg.kg-1 PMID[412968]
NPT713 Individual Protein Bile salt export pump Homo sapiens IC50 > 133000.0 nM PMID[23956101]
NPT19 Organism Escherichia coli Escherichia coli Inhibition = 2.79 % DOI[10.6019/CHEMBL4296181]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa Inhibition = 1.62 % DOI[10.6019/CHEMBL4296181]
NPT20 Organism Candida albicans Candida albicans Inhibition = -0.39 % DOI[10.6019/CHEMBL4296181]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans Inhibition = -1.83 % DOI[10.6019/CHEMBL4296181]
NPT2922 Organism Staphylococcus aureus subsp. aureus Staphylococcus aureus subsp. aureus Inhibition = -14.43 % DOI[10.6019/CHEMBL4296181]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae Inhibition = 1.69 % DOI[10.6019/CHEMBL4296181]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii Inhibition = -6.71 % DOI[10.6019/CHEMBL4296181]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC489610 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC489610 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data